Search results
Results from the WOW.Com Content Network
Sensory modulation disorder SMEI Severe myoclonic epilepsy of infancy: SMS Smith–Magenis syndrome: SOD Septo-optic dysplasia: SPD Sensory processing disorder: SPS Stiff person syndrome: SSPE Subacute sclerosing panencephalitis: STEMI ST-elevation myocardial infarction: STD Sexually transmitted disease: STI Sexually transmitted infection: SUNCT
Note: many adolescents and young adults may have CDD but were never tested since such tests were not available when they were infants. Therefore, epilepsy panels for CDD and other genes should be considered in such individuals. [8] A diagnostic ICD-10 code has been assigned to CDKL5 deficiency disorder: G40.42 (since 2020). [9]
Ohtahara syndrome (OS), also known as Early Infantile Developmental & Epileptic Encephalopathy (EIDEE) [2] is a progressive epileptic encephalopathy.The syndrome is outwardly characterized by tonic spasms and partial seizures within the first few months of life, [3] and receives its more elaborate name from the pattern of burst activity on an electroencephalogram (EEG).
ICD-10 is the 10th revision of the International Classification of Diseases (ICD), a medical classification list by the World Health Organization (WHO). It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases. [1]
Status epilepticus (SE), or status seizure, is a medical condition consisting of a single seizure lasting more than 5 minutes, or 2 or more seizures within a 5-minute period without the person returning to normal between them. [3] [1] Previous definitions used a 30-minute time limit. [2]
This is an alphabetically sorted list of all mental disorders in the DSM-IV and DSM-IV-TR, along with their ICD-9-CM codes, where applicable. The DSM-IV-TR is a text revision of the DSM-IV. [1] While no new disorders were added in this version, 11 subtypes were added and 8 were removed. This list features both the added and removed subtypes.
Ganaxolone (brand name Ztalmy) was approved for medical use in the United States in March 2022 [22] [23] and considered by the US Food and Drug Administration (FDA) to be a first-in-class medication. [24] Ganaxolone, a neuroactive steroid gamma-aminobutyric acid (GABA) A receptor positive modulator, treats seizures in those with CDKL5 ...
[3] [7] If it is a person's first seizure and it was "provoked", or caused by another condition, treatment of the cause is usually enough to treat the seizure. [3] If the seizure is "unprovoked", brain imaging is abnormal, and/or EEG is abnormal, starting anti-seizure medications is generally recommended. [3] [7] [14]